Shanghai, China, May 26th, 2020. Elpiscience Biopharma Ltd., a clinical stage biotech company focusing on the discovery and development of next-generation cancer immunotherapies, today announced that Dr. Darren Ji, Chief Executive Officer, will present an update on company business and R&D pipeline at the Jefferies 2020 Healthcare Conference, at 21:30 Beijing China time (9:30am ET, U.S.), on June 4th.
A live webcast of the Presentation can be retrieved through the link as below: http://wsw.com/webcast/jeff126/elp/
Elpiscience is a clinical-stage biopharmaceutical company focusing on cancer immunotherapy. The company is committed to leading the next generation of cancer immunotherapies for the benefit of cancer patients worldwide. Elpiscience has a pipeline of more than 10 innovative molecules with its most advanced assets, ES101 and ES102, already in clinical trials. Elpiscience’s innovations cover a wide range of immunology targets with a focus on innate immunity and tumor microenvironment. For more information please visit: http://www.elpiscience.com.